A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Organon

Status and phase: Completed; Phase 4

Conditions: Osteoarthritis

Treatments: Drug: Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks; Drug: MK0663; etoricoxib / Duration of Treatment:4 Weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00140972

2005_060

MK0663-080

0663-080

Details and patient eligibility

About

A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip

Enrollment: 160 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Chinese males or females at least 40 years of age with osteoarthritis of the knee or hip

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind